Filing · LD-2 quarterly report
Q1 amendment
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted May 2, 2026
Expenses
$23,005
What this organization spent lobbying with its own staff.
Reported using IRS section 6033(b)(8) definitions (method B): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
California
Government bodies contacted
2
Lobbying activity
3
H.R. 9747, (P.L. 118-83) the FY2025 Continuing Appropriations and Extensions Act: Cancer Research, Appropriations: Cancer Research, NIH, CDC, NCI, DoD, ARPA-H,
Access Issues, Cancer Drug Parity Act, Safe Step Act, Seniors Timely Access to Care Act
CDMRP's PRCRP
Bills named in this filing
1